http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#head
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#provenance
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion
http://rdf.disgenet.org/resource/gda/DGN47f0c26e2d821e9bb2d5172965b7bfc0
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/5609
http://rdf.disgenet.org/resource/gda/DGN47f0c26e2d821e9bb2d5172965b7bfc0
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C1140680
http://rdf.disgenet.org/resource/gda/DGN47f0c26e2d821e9bb2d5172965b7bfc0
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001123
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#provenance
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion
http://purl.org/dc/terms/description
[We assess key issues in anti-angiogenic treatment including potential ways for addressing resistance; we review the current studies of PARP inhibitor treatment, which shows most promise in patients with germline BRCA mutations; we describe the potential for folate-receptor-directed therapy, given the high level of FR expression in ovarian cancer and we highlight the potential for molecular targeted therapy, focusing on specific subgroups of the disease with targets such as the PI3 K/AKT and RAS/RAF/MEK pathways and the ErbB family of oncogenes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/24265409
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/dc/terms/created
2017-10-17T13:15:39+02:00
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0